“[...] PHA is a rare yet aggressive mesenchymal tumor of the liver, which requires a multi-disciplinary approach to achieve the best patient outcomes.” “In our ...
Two rare presentations and treatments of Ewing's sarcoma: A need for a standard treatment approach. Pilot study of redirected autologous T cells engineered to contain anti-CD19 attached to TCRζ and ...
Loss of the DNA repair gene RNase H2 and a unique subset of DDR-deficient leiomyosarcomas. Phase 1 trial of avelumab with hypofractionated thoracic radiation therapy (HT-RT) in patients with ...
Liver involvement by KS occurs only in acquired immune deficiency syndrome (AIDS) patients and is usually associated with KS lesions elsewhere. KS lesions are seen in 12 to 25% of fatal cases in this ...
This is a preview. Log in through your library . Abstract In the December 1974 issue of the Journal of Occupational Medicine (16:809), NIOSH presented data on 26 cases of liver angiosarcoma among ...
Vision – To be the world's leading and most trusted provider of information and services that will make a real difference in clinical practice and improve outcomes for patients. Mission – To lead the ...
In a new study published in the journal Nature Medicine on February 2020, scientists report some newly discovered reasons for the occurrence of a rare blood vessel wall cancer called angiosarcoma.
GAITHERSBURG, Md. and SUZHOU BIOBAY, China, June 24, 2021 /PRNewswire/ -- Sirnaomics, Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results